The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach

American Journal of Ophthalmology

Volumn 150, Issue 1, 2010, Pages 74-81

  Kymes, Steven M ^a   Plotzke, Michael R ^a,b   Li, Jim Z ^c   Nichol, Michael B ^d   Wu, Joanne ^d   Fain, Joel ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ABT ASSOCIATES   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANALYTIC METHOD; ARTICLE; BLINDNESS; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DEMENTIA; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HIDDEN MARKOV MODEL; HIP FRACTURE; HOME CARE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SERVICE; MEDICARE; NURSING HOME; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIMULATION; UNITED STATES; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; DECISION SUPPORT TECHNIQUES; FEMALE; GLAUCOMA, OPEN-ANGLE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; MALE; MARKOV CHAINS; MEDICARE; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; VISION DISORDERS; VISUALLY IMPAIRED PERSONS;

EID: 77953913599     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.01.037     Document Type: Article

References (32)

1. Congdon N., O'Colmain B., Klaver C.C., et al., Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
2. Friedman D.S., Congdon N., Kempen J., and Tielsch J.M. Vision Problems in the United States (2002), National Eye Institute, Washington, DC
3. Sommer A., Tielsch J.M., Katz J., et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 325 (1991) 1412-1417
4. Robin A.L., Frick K.D., Katz J., Budenz D., and Tielsch J.M. The Ocular Hypertension Treatment Study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?. Arch Ophthalmol 122 (2004) 376-378
5. Rice D.P. Cost of illness studies: what is good about them?. Inj Prev 6 (2000) 177-179
6. Javitt J.C., Zhou Z., and Willke R.J. Association between vision loss and higher medical care costs in Medicare beneficiaries' costs are greater for those with progressive vision loss. Ophthalmology 114 (2007) 238-245
7. Frick K.D., Gower E.W., Kempen J.H., and Wolff J.L. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 125 (2007) 544-550
8. Rein D.B., Zhang P., Wirth K.E., et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 124 (2006) 1754-1760 erratum appears in Arch Ophthalmol 2007;125:1304
9. Lee P.P., Levin L.A., Walt J.G., et al. Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data. Ophthalmology 114 (2007) 1241-1247
10. Gieser D.K., Tracy Williams R., O'Connell W., et al. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. J Glaucoma 15 (2006) 419-425
11. Iskedjian M., Walker J., Vicente C., et al. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment. J Glaucoma 12 (2003) 456-462
12. Lee P.P., Walt J.G., Doyle J.J., et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 124 (2006) 12-19
13. Neymark N., Buchholz P., Honrubia F., and Kobelt G. The costs of treating glaucoma with combinations of topical drugs in Spain. Eur J Ophthalmol 18 (2008) 52-59
14. Employer Health Benefits: 2007 Annual Survey (2008), Henry J. Kaiser Family Foundation and Health Research and Education Trust, Washington, DC. http://www.kff.org/insurance/7672/upload/76723.pdf Accessed May 28, 2009
15. Beals J., Welty T.K., Mitchell C.M., et al. Different factor loadings for SF36: the Strong Heart Study and the National Survey of Functional Health Status. J Clin Epidemiol 59 (2006) 208-215
16. Wang J.J., Mitchell P., Cumming R.G., Smith W., and Blue Mountains Eye S. Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study. Ophthalmic Epidemiol 10 (2003) 3-13
17. Charlson M.E., Szatrowski T.P., Peterson J., and Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
18. Hunt S., Maerki S., and Tompkins R. Comparing CPT codes payments for Medi-Cal and other California payers: California Healthcare Foundation, 2001. http://www.chcf.org/topics/medi-cal/index.cfm?itemID=20413 Accessed June 17, 2008
19. Weinstein M.C. Recent developments in decision-analytic modeling for economic evaluation. Pharmacoeconomics 24 (2006) 1043-1053
20. Brody B.L., Gamst A.C., Williams R.A., et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 108 (2001) 1893-1901
21. Jampel H.D., Frick K.D., Janz N.K., et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 144 (2007) 238-244
22. Koch J.M., Datta G., Makhdoom S., and Grossberg G.T. Unmet visual needs of Alzheimer's disease patients in long-term care facilities. J Am Med Dir Assoc 6 (2005) 233-237
23. Ivers R.Q., Mitchell P., and Cumming R.G. Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. Clin Exper Ophthalmol 28 (2000) 41-47
24. Coleman A.L., Stone K., Ewing S.K., et al. Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology 111 (2004) 857-862
25. Beck J.R., and Pauker S.G. The Markov process in medical prognosis. Med Decis Making 3 (1983) 419-458
26. Akbari M., Akbari S., and Pasquale L.R. The association of primary open-angle glaucoma with mortality: a meta-analysis of observational studies. Arch Ophthalmol 127 (2009) 204-210
27. Willet J.B., and Singer J.D. Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J Consult Clin Psychol 61 (1993) 952-965
28. Bramley T., Peeples P., Walt J.G., Juhasz M., and Hansen J.E. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol 126 (2008) 849-856
29. Drummond M.F., Schulpher M.J., Torrance G.W., O'Brien B., and Stoddart G.L. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. (2005), Oxford University Press, Oxford
30. Goldberg I., Clement C.I., Chiang T.H., et al. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma 18 (2009) 6-12
31. Skalicky S., and Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 17 (2008) 546-551
32. Varma R., Wu J., Chong K., Azen S.P., Hays R.D., and Los Angeles Latino Eye Study G. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113 (2006) 1846-1853